ViRexx Medical Corp.

Canadian Trademark Information

Vaccine designed to stimulate anti-viral cytotoxic T cells in patients suffering from chronic Hepatitis B. Research and development and commercialization in the field of immunotherapy, vaccines and novel therapeutic approaches to treat chronic infectious diseases.
Classification Information
Class Code: 042 - Computer & Software Services & Scientific Services
Description: Computer and scientific
Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals, herbicides and veterinary products
Matter History Events
Status Date Record Status Description
2009-09-24 Registration surrendered - cancelled by Owner
2005-05-09 Registration published - registered
2004-05-11 National prosecution history entry - Amendment to Application
2003-11-07 National prosecution history entry - allowed
2003-11-07 National prosecution history entry - allowance notice sent
2003-08-20 Application published - advertised
2003-08-06 National prosecution history entry - Extracted for Advertisement
2003-07-17 Application accepted - approved
2003-03-26 Filing date accorded - Search Recorded
2003-03-26 National prosecution history entry - Examiner's First Report
2003-02-18 National prosecution history entry - change of title registered
2002-05-27 Filing date accorded - formalized
2002-04-25 National prosecution history entry - created
2002-04-19 Application filed - filed
Word Mark: Logo Mark
Current Status:
Registration surrendered
DEAD Mark!
9/24/2009
Application Number: 1138079
Filing Date: Friday, April 19, 2002
Filing Place: Canada
Registration Date: Monday, May 9, 2005
Registration Number: TMA639332
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Figurative
Mark Disclaimer: The right to the exclusive use of the word CURE is disclaimed apart from the trade-mark.
Use In Commerce: Yes
Publication Registration: Wednesday, August 20, 2003
Opposition: 8/20/2003 - 8/20/2003
Last Applicant/Owner: *********
**********
***** ****
Correspondent:
*********
**********
***** ****
Logo Design Information
Design Feature:
(1) Letters presenting a special form of writing
(2) Letters overlapping
Goods and Services Information
Description:
(1) - Vaccine designed to stimulate anti-viral cytotoxic T cells in patients suffering from chronic Hepatitis B.
(2) - Research and development and commercialization in the field of immunotherapy, vaccines and novel therapeutic approaches to treat chronic infectious diseases.
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
What You Can Do:

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!
As seen on